Krokos Bio
PrivateLast Round
Grant
Aug 19, 2025
Total Funding Raised
$305,000
Company Overview
Krokos Bio operates in Healthcare & Life Sciences and is based in Davis, California. Its latest recorded funding round was a Grant round in August 2025.
Krokos Bio is a biotechnology company that develops plant cell culture technology to produce high-value botanical ingredients, starting with lab-grown saffron.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Sustainable Materials
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Krokos Bio Comparables
Compare Krokos Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spicy Cells | 91% | |
| Novella Innovative Technology | 86% | |
| Chi Botanic | 86% |
For institutional investors. Book with your work email.
Krokos Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 19, 2025 | ||||
| Accelerator | Jul 15, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Krokos Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Big Idea Ventures | Accelerator |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 19, 2025
$305K grant from the National Science Foundation.
- Jul 15, 2025
Led by Big Idea Ventures
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asSep 7, 2026
At the fifth annual Pitch Elk Grove contest in California, judges including investors from Moneta Ventures, the Growth Factory, Sacramento Angels and Bay Angels recognize Krokos Bio Inc. as the top pitch among 10 companies and award it the top $10,000 cash prize in Sep '26.
For institutional investors. Book with your work email.
Krokos Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Krokos Bio's valuation, stock price, and market status.
Is Krokos Bio a public or private company?
Krokos Bio is a private company.
What is the current stock price of Krokos Bio?
Krokos Bio is a private company, so its shares have no public market price. Caplight tracks Krokos Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Krokos Bio worth (valuation)?
Valuation information for Krokos Bio is not publicly available.
Can I buy Krokos Bio stock?
Krokos Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Krokos Bio's last funding round?
Krokos Bio's most recent funding round was Grant on August 19, 2025.
Who are the main investors in Krokos Bio?
Key investors in Krokos Bio include Big Idea Ventures.
Will Krokos Bio IPO soon?
No public IPO plans have been announced for Krokos Bio.
How can I track Krokos Bio secondary market activity?
Caplight tracks bids, offers, and trades in Krokos Bio's shares on secondary markets.